July 16, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — Neurological and pancreatic complications are common in patients with congenital hyperinsulinism, according to a systematic review presented at ENDO 2026. “The goal of this work was to systematically synthesize the [congenital hyperinsulinism] literature and critically evaluate evidence that is often cited but derived from relatively small studies,” Brian K. Roberts, MD, chief medical
July 16, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CHICAGO — At 2 years, crinecerfont demonstrated favorable effects on weight, body composition and insulin resistance in adults…

CHICAGO — In a cohort of patients with difficult-to-control type 2 diabetes, approximately one-quarter had hypercortisolism,…

CHICAGO — Patients with idiopathic intracranial hypertension lost weight and had fewer headaches with GLP-1 receptor agonists,…

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM,…

Recent data reveal a striking paradox: While 73% of endocrinologists prescribe glucose-lowering medications, fewer than 10% of…

CHICAGO — Major diabetic foot complications were more common in patients with type 2 diabetes treated with SGLT2 inhibitors than…